MyFinsight
Home
Blog
About
Belbuca
$57,669K
(9.64%↑ Y/Y)
Jornay Pm
$46,058K
(41.17%↑ Y/Y)
Xtampza ER
$45,006K
Nucynta ER
$15,723K
Nucynta IR
$14,356K
Azstarys
$12,910K
Symproic
$3,020K
(-18.86%↓ Y/Y)
Nucynta ERAG
$2,775K
Nucynta IRAG
$2,361K
Product revenues, net
$199,878K
(6.32%↑ Y/Y)
Net (loss) income
-$15,051K
(-225.60%↓ Y/Y)
Gross profit
$110,292K
(1.76%↑ Y/Y)
Total cost of product
revenues
$89,586K
(12.52%↑ Y/Y)
(loss) income before
income taxes
-$13,532K
(-179.48%↓ Y/Y)
Provision for income taxes
$1,519K
(-69.87%↓ Y/Y)
Income from operations
$3,698K
(-89.47%↓ Y/Y)
Interest income
$2,289K
(-3.94%↓ Y/Y)
Total operating
expenses
$106,594K
(45.46%↑ Y/Y)
Intangible asset
amortization
$62,953K
Cost of product
revenues (excluding...
$26,633K
(10.31%↑ Y/Y)
Interest expense
$19,519K
(-4.61%↓ Y/Y)
Selling, general and
administrative
$106,594K
(44.76%↑ Y/Y)
Back
Back
Income Statement
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)
source: myfinsight.com